Absci | Investor Presentation Deck | 27 slides · page 17 of 27
The slide illustrates a process flow from target antigen/epitope to AI-generated antibody scaffold, followed by wet lab validation (ACE/SPR assays) to identify binders.
Pitch deck · solution · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 3/3
diagram 1/1 list 1/1 title 1/1
Components 3
process bullet headline
Tools 2
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1